- Home
- INBX vs DEA Comparison
INBX vs DEA Comparison
Compare INBX & DEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INBX | DEA |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 999.7M | 1.0B |
| IPO Year | 2024 | 2014 |
Fundamental Metrics
Financial Performance| Metric | INBX | DEA |
|---|---|---|
| Price | $111.28 | $22.92 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 5 |
| Target Price | ★ $150.00 | $23.49 |
| AVG Volume (30 Days) | ★ 586.3K | 296.0K |
| Earning Date | 05-15-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 7.77% |
| EPS Growth | N/A | ★ 50.00 |
| EPS | N/A | ★ 0.02 |
| Revenue | $1,300,000.00 | ★ $336,099,000.00 |
| Revenue This Year | N/A | $5.41 |
| Revenue Next Year | N/A | $3.33 |
| P/E Ratio | ★ N/A | $1,151.00 |
| Revenue Growth | ★ 550.00 | 11.27 |
| 52 Week Low | $12.80 | $20.56 |
| 52 Week High | $155.29 | $24.94 |
Technical Indicators
Market Signals| Indicator | INBX | DEA |
|---|---|---|
| Relative Strength Index (RSI) | 50.41 | 48.15 |
| Support Level | $69.30 | $20.89 |
| Resistance Level | $155.29 | $23.88 |
| Average True Range (ATR) | 13.20 | 0.48 |
| MACD | -3.55 | -0.08 |
| Stochastic Oscillator | 23.22 | 27.73 |
Price Performance
Historical ComparisonAbout INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About DEA Easterly Government Properties Inc.
Easterly Government Properties Inc is a real estate investment trust. The company is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. It generates all its revenue by leasing its properties to such agencies. The company operates in single segment for the purposes of assessing performance and making operating decisions.